betway必威登陆网址|betway.com|betway必威亚洲|betway8881

Journal of International Oncology››2021,Vol. 48››Issue (11): 643-648.doi:10.3760/cma.j.cn371439-20210621-00128

Previous Articles Next Articles

Received:2021-06-21Revised:2021-08-20Online:2021-11-08Published:2021-12-14

Abstract

Figures/Tables3

"

危及器官	剂量体积参数
胃	$D 0.5 c m 3$ <33 Gy(最优),<35 Gy(强制); $D 5 c m 3$ <25 Gy(最优); $D 10 c m 3$ <25 Gy(强制); $D 50 c m 3$ <12 Gy(最优)
十二指肠	$D 0.5 c m 3$ <35 Gy(强制); $D 1 c m 3$ <33 Gy(最优); $D 5 c m 3$ <25 Gy(最优); $D 9 c m 3$ <15 Gy(最优); $D 10 c m 3$ <25 Gy(强制)
小肠	$D 0.5 c m 3$ <30 Gy(最优),<35 Gy(强制); $D 5 c m 3$ <25 Gy(最优); $D 10 c m 3$ <25 Gy(强制)
肝脏	超过10 Gy受照剂量的体积小于总体积70%,D_mean<13 Gy(最优),<15.2 Gy(强制)

"

危及器官	剂量体积参数
脊髓	D_max<30 Gy, $D 0.35 c m 3$ <23 Gy, $D 1.2 c m 3$ <14.5 Gy
胃	D_max<32 Gy, $D 10 c m 3$ <18 Gy
十二指肠	D_max<32 Gy, $D 5 c m 3$ <18 Gy, $D 10 c m 3$ <12.5 Gy
空回肠	D_max<35 Gy, $D 5 c m 3$ <19.5 Gy
肝脏	小于21 Gy受照剂量的体积大于700 cm³

"

危及器官	剂量体积参数
十二指肠	$D 1 c m 3$ ≤50 Gy, $D 3 c m 3$ ≤45 Gy, $D 5 c m 3$ ≤40 Gy
胃、小肠、结肠	$D 1 c m 3$ ≤55 Gy, $D 3 c m 3$ ≤50 Gy, $D 5 c m 3$ ≤45 Gy

References13

[1]	Garrido-Laguna I, Hidalgo M. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies[J]. Nat Rev Clin Oncol, 2015, 12(6):319-334. DOI: 10.1038/nrclinonc.2015.53. doi:10.1038/nrclinonc.2015.53pmid:25824606
[2]	Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1):7-30. DOI: 10.3322/caac.21590. doi:10.3322/caac.v70.1
[3]	Zhu X, Li F, Liu W, et al. Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: a propensity score-matched analysis of a prospectively collected database[J]. Cancer Manag Res, 2018, 10:1295-1304. DOI: 10.2147/CMAR.S163655. doi:10.2147/CMAR
[4]	Mellon EA, Hoffe SE, Springett GM, et al. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma[J]. Acta Oncol, 2015, 54(7):979-985. DOI: 10.3109/0284186X.2015.1004367. doi:10.3109/0284186X.2015.1004367pmid:25734581
[5]	Tchelebi LT, Lehrer EJ, Trifiletti DM, et al. Conventionally fractio-nated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): an international systematic review and meta-analysis[J]. Cancer, 2020, 126(10):2120-2131. DOI: 10.1002/cncr.32756. doi:10.1002/cncr.32756pmid:32125712
[6]	Lischalk JW, Burke A, Chew J, et al. Five-fraction stereotactic body radiation therapy (SBRT) and chemotherapy for the local management of metastatic pancreatic cancer[J]. J Gastrointest Cancer, 2018, 49(2):116-123. DOI: 10.1007/s12029-016-9909-2. doi:10.1007/s12029-016-9909-2
[7]	Ren G, Zhu F, Wang YJ, et al. A phase Ⅱ study of oral S-1 with concurrent hypofractionated simultaneous integrated boost radiotherapy for metastatic pancreatic cancer using helical tomotherapy[J]. J Clin Oncol, 2017, 35(15_suppl):e15720. DOI: 10.1200/JCO.2017.35.15_suppl.e15720. doi:10.1200/JCO.2017.35.15_suppl.e15720
[8]	Ren G, Feng Z, Zhu F, et al. A phase Ⅰ trial of high-dose sbrt followed by the gastrointestinal shunt procedure for local pancreatic head and neck carcinoma: to approach a new mode of cooperation of radiotherapy and surgery[J]. Int J Radiat Oncol Biol Phys, 2018, 102(3S):e78. DOI: 10.1016/j.ijrobp.2018.07.431.
[9]	夏廷毅, 孙庆选, 于涌, 等. 体部γ刀治疗52例胰腺癌的疗效分析[J]. 中华肝胆外科杂志, 2006, 12(2):86-88. DOI: 10.3760/cma.j.issn.1007-8118.2006.02.006.
[10]	常冬姝, 夏廷毅, 李平, 等. 全身γ刀治疗局限期胰腺癌临床结果分析[J]. 中华放射肿瘤学杂志, 2009, 18(6):470-473. DOI: 10.3760/cma.j.issn.1004-4221.2009.06.470.
[11]	任刚, 夏廷毅. 胰腺癌放疗剂量模式改变的研究进展[J]. 中华结直肠疾病电子杂志, 2016, 5(2):121-126. DOI: 10.3877/cma.j.issn.2095-3224.2016.02.03.
[12]	Hanna GG, Murray L, Patel R, et al. UK consensus on normal tissue dose constraints for stereotactic radiotherapy[J]. Clin Oncol, 2018, 30(1):5-14. DOI: 10.1016/j.clon.2017.09.007. doi:10.1016/j.clon.2017.09.007
[13]	吴伟章, 朱夫海, 王勇. Tomotherapy摆位误差修正的精度及其对PTV外放边界的影响[J]. 实用肿瘤杂志, 2016, 31(2):53-56. DOI: 10.13267/j.cnki.syzlzz.2016.02.020.

Related Articles0

Recommended Articles

Metrics

Comments